Not sure if they fully withdrew it or not, but they did direct the stock they had allocated towards it elsewhere. So possibly.
Fonterra also commented quite awhile back in the media that they had responded to some FDA questions about their application (which seems to suggest it was being actively reviewed).
Ann: a2MC notes and responds to media speculation, page-74
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.32 |
Change
-0.050(0.78%) |
Mkt cap ! $4.612B | |||
| Open | High | Low | Value | Volume |
| $6.33 | $6.52 | $6.29 | $5.766M | 895.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 16639 | $6.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.33 | 9263 | 16 |
View Market Depth
| Last trade - 13.36pm 08/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |